COMPOSITIONS AND METHODS FOR EX VIVO EXPANSION OF HUMAN HEMATOPOIETIC STEM/PROGENITOR CELLS

Described herein are methods of genetically modifying a quantity of expanded hematopoietic cells, comprising providing a quantity of hematopoietic cells; culturing the quantity of hematopoietic cells in the presence of at least one histone deacetylase inhibitor (HDACi) and at least one growth factor...

Full description

Saved in:
Bibliographic Details
Main Authors CHAI, Li, BRADNER, James Elliot, TATETSU, Hiro, TENEN, Daniel Geoffrey, FEDERATION, Alexander
Format Patent
LanguageEnglish
French
German
Published 17.02.2021
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Described herein are methods of genetically modifying a quantity of expanded hematopoietic cells, comprising providing a quantity of hematopoietic cells; culturing the quantity of hematopoietic cells in the presence of at least one histone deacetylase inhibitor (HDACi) and at least one growth factor to expand the hematopoietic cells; and contacting the expanded hematopoietic cells with a nucleic acid sequence. The nucleic acid sequence modifies the quantity of expanded hematopoietic cells. Also described are compositions comprising the quantity of expanded hematopoietic cells produced.
Bibliography:Application Number: EP20200190771